We initially asked whether both GGHI/VSVG and GGHI-mB-3D/VSVG γ-globin vectors (Figure 1A), previously tested on CD34+ cells from thalassemia patients [32,38], could increase the Aγ/α ratio in SCD patients as well. Here, RENBP is linked to thalassemia.